Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT04071613
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 104 participants
- Sponsor
- Melbourne Health
- Registry
-
NCT04071613
-
- Other papers using this trial's data
- Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia
- Registry status
- Completed
Technical summary
Registry record NCT04071613. Randomized; single masking; primary purpose treatment. Start 2019-06-20 (actual); primary completion 2021-11-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance
- Acronym
- TASTEa
- Condition
- Stroke, Acute, Stroke Ischemic
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- Intravenous tissue plasminogen activator (tPA)
- Lead sponsor
- Melbourne Health
Record details
- Record id
cardio:ct-nct04071613- Content hash
3e4f33d9e7ea1499736a3861e082db4204728199b5cb0a0aa36bd4f4d46c8ee5